Home / Recalls / Ascend Laboratories LLC / D-0178-2021

D-0178-2021 Class II Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
January 6, 2021
Initiation Date
December 17, 2020
Termination Date
May 3, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
29,317 bottles

Product Description

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 100 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88

Reason for Recall

Failed Impurity/Degradation Specifications

Distribution Pattern

Nationwide

Code Information

20141674, 20141675, 20141676, 20141677, 20141678,

Other recalls by Ascend Laboratories LLC

  • D-0017-2026 Class II — Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-5 (September 19, 2025)
  • D-0020-2026 Class II — Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90) (September 19, 2025)
  • D-0018-2026 Class II — Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-9 (September 19, 2025)
  • D-0019-2026 Class II — Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90) (September 19, 2025)
  • D-0645-2025 Class II — Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Al (August 28, 2025)
  • D-0576-2025 Class II — Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx On (July 21, 2025)
  • D-0534-2025 Class II — Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, M (July 9, 2025)
  • D-0533-2025 Class II — Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Ma (July 9, 2025)
  • D-0468-2025 Class II — Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx On (May 23, 2025)
  • D-0469-2025 Class II — Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx On (May 23, 2025)